Last reviewed · How we verify
NCT03902275
Validation of a Quantra Supported Hemotherapy Algorithm in Cardiac Surgery
NA trial testing Quantra-Algorithm in Hemorrhage in 20 participants. Terminated before completion.
1 December 2019
Quick facts
| Lead sponsor | Johann Wolfgang Goethe University Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 July 2019 |
| Primary completion | 1 December 2019 |
| Estimated completion | 1 June 2020 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Quantra-Algorithm
- ROTEM-Algorithm
Conditions studied
- Hemorrhage — all drugs for Hemorrhage →
- Bleeding — all drugs for Bleeding →
Sponsor
Johann Wolfgang Goethe University Hospital
Who can join
18 and older, any sex, with Hemorrhage or Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to develop a coagulation algorithm based on Quantra POCT for the treatment of coagulopathic cardiac surgery patients.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Hemostatis Analyzer-Supported Hemotherapy Algorithm in Cardiac Surgery: Protocol for a Randomized Controlled Monocentric Trial.
Michel S, Piekarski F, Fischer JH, Hettler V, et al · · 2020 · cited 1× · PMID 32314972 · DOI 10.2196/17206
Verify or expand the search:
- PubMed search for NCT03902275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemorrhage
Currently open trials in the same condition.
- NCT07311343 — Oral Hygiene and Prophylactic Antibiotics to Prevent Intracerebral Hemorrhage Associated Pneumonia · Phase 4 · recruiting
- NCT07105904 — Biological and Clinical Relevance of Quantra Viscoelastic Hemostatic Assay in Hemorrhagic Cardiac Surgery · active not recruiting
- NCT06979466 — Q Therapeutic System for Chronic Stroke Recovery · NA · recruiting
- NCT06664775 — A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate S · Phase 3 · recruiting
- NCT06304714 — Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana · recruiting
Other Johann Wolfgang Goethe University Hospital trials
Trials by the same sponsor.
- NCT05921136 — Recycling Potential in Endoscopy - a Multicentre Prospective Observational Study · unknown
- NCT04739020 — Respiratory Aerosols in Patients With COVID-19 and Healthy Controls · NA · unknown
- NCT04975490 — Characterization and Pathogenesis of ACLF · unknown
- NCT04546867 — Establishing a Sonographic Based Algorithm to Verify Pancreatic Stent Position Placed to Prevent Post-ERCP Pancreatitis · NA · completed
- NCT04476498 — Prospective Comparison of Pull-PEG and Pull-PEG With Gastropexy · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03902275 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Johann Wolfgang Goethe University Hospital
- Last refreshed: 2 July 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03902275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing